Coronavirus Update: Novartis Joins Antiviral Therapies Search With Novel DARPin Alliance
Plus: Japan Passes Bill For Free Vaccines
Swiss biotech Molecular Partners will receive upfront payment of CHF60m, including equity.
You may also be interested in...
Drug fails to save lives in study and follows disappointments from Roche and Regeneron/Sanofi's IL-6 inhibitors.
Pharma pays $50m up front to tap insitro’s in vitro modeling technology, partners with Sensyne Health in blood disorders. Lilly’s COVID-19 partner AbCellera teams with Kodiak in ophthalmology R&D.
US FDA will hold 10 December advisory committee on Pfizer/BioNTech's just-filed application; the WHO issued a recommendation against Gilead's Veklury for hospitalized patients.